IRF9 and neoplasm: Conversely, restoring IFN-β expression in OSM-expressing TNBC cells restored the expression of select ISGs (including STAT1, STAT2, IRF9, SOCS1, MX1, and OAS1 and reduced tumor sphere formation and tumor-initiating capacity.